【丹麦】诺和诺德基金会与科技巨头英伟达联手，计划在丹麦建设一座名为Gefion的AI超级计算机，以加速新药和疗法的创新研发。据科创板日报报道，这一重大合作项目于当地时间3月18日正式宣布，旨在利用尖端的人工智能技术推动医疗科研的进步。
Gefion超级计算机将搭载英伟达的先进AI平台，为丹麦的公共和私营部门研究人员提供强大的计算能力，帮助他们在药物发现和治疗方案探索中实现突破。诺和诺德基金会，作为全球知名制药企业诺和诺德背后的支持力量，此次与英伟达的合作，显示出其对科技创新在医疗领域应用的坚定承诺。
这一合作项目不仅有望提升丹麦在全球医疗研究领域的地位，还将为全球健康问题的解决提供新的可能。通过AI技术的深度学习和大数据分析能力，研究人员能够更高效地筛选潜在药物分子，缩短新药研发周期，降低研发成本，从而更快地将创新疗法推向市场，惠及广大患者。
Gefion超级计算机的建设，预示着AI技术在医药研发中的应用将达到新的高度，同时也为未来公共与私营部门的科研合作树立了典范。随着项目的推进，我们期待看到更多的科研成果涌现，为全球医疗健康事业注入新的活力。
英语如下：
**News Title:** “Novo Nordisk Foundation and NVIDIA Team Up: Building an AI Supercomputer to Revolutionize Drug Discovery”
**Keywords:** AI Supercomputer, Novo Nordisk, Drug Discovery
**News Content:**
The Novo Nordisk Foundation, in collaboration with tech giant NVIDIA, plans to construct an AI supercomputer named Gefion in Denmark, aiming to accelerate innovation in drug and therapy development. According to The科创板Daily, this significant partnership was officially announced on March 18, local time, with the goal of advancing medical research through cutting-edge artificial intelligence technology.
Equipped with NVIDIA’s advanced AI platform, the Gefion supercomputer will provide powerful computational capabilities to researchers from both Denmark’s public and private sectors, enabling breakthroughs in drug discovery and treatment exploration. The Novo Nordisk Foundation, the driving force behind the renowned pharmaceutical company Novo Nordisk, demonstrates its commitment to innovation in healthcare through this collaboration with NVIDIA.
This partnership not only has the potential to elevate Denmark’s position in global medical research but also offers new possibilities for addressing global health challenges. By leveraging AI’s deep learning and big data analysis capabilities, researchers can more efficiently screen potential drug molecules, shorten drug development timelines, and reduce costs, thereby expediting the introduction of innovative therapies to the market and benefiting a broad patient population.
The construction of the Gefion supercomputer signifies a new peak in the application of AI technology in pharmaceutical research and sets a benchmark for future public-private sector research collaborations. As the project progresses, we anticipate a surge of scientific achievements that will infuse new vitality into the global healthcare sector.
【来源】https://www.chinastarmarket.cn/detail/1624366
Views: 1